Michelle McMurry-Heath (BIO via YouTube)
October 11, 2022 04:25 AM EDTUpdated October 13, 06:43 AM
Bioregnum

Michelle Mc­Mur­ry-Heath washed over­board at BIO as in­dus­try group wres­tles over its fu­ture, hunts new CEO

In the end, the in­ter­nal ten­sions rip­ping at BIO had bare­ly sur­faced in fresh tur­moil then the stormy sur­face wa­ters were smoothed by CEO Michelle …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times